a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with F Files

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2V057AP

  • Date of Issuance: 16-Apr-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2W001AM

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2W014AA

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2T084AE

  • Date of Issuance: 11-Apr-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2U017AS

  • Date of Issuance: 28-Aug-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2U024BAH

  • Date of Issuance: 28-Aug-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2W001AM

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U017AD

  • Date of Issuance: 20-Jun-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2S087AF

  • Date of Issuance: 1-Aug-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AB

  • Date of Issuance: 7-Nov-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AN

  • Date of Issuance: 16-Nov-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AN

  • Date of Issuance: 16-Nov-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T079AB

  • Date of Issuance: 11-Apr-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T079AG

  • Date of Issuance: 13-May-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U023AF

  • Date of Issuance: 24-Sep-19
[12 3 4 5  >>  

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Isnin 06 Disember 2021, 15:06:23.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Choose Your Language

Menu Utama